Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC

R. Pili, M.A. Rosenthal, P.N. Mainwaring, Guy Van Hazel, S. Srinivas, R. Dreicer, S. Goel, J. Leach, S. Wong, P. Clingan

    Research output: Contribution to journalArticlepeer-review

    52 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2906-2914
    JournalClinical Cancer Research
    Issue number10
    Publication statusPublished - 2010

    Cite this